Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1995-04-24
1997-12-23
Tsang, Cecilia J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 2, 514911, 530381, 530382, 530817, 424422, 424430, 424558, A61K 3800, A61K 3514, A61F 606
Patent
active
057007837
ABSTRACT:
A method for treating urinary incontinence consisting of injecting human fibrin glue at or near the bladder neck until the urethral outflow resistance is restored. Human fibrin glue is the reaction product of human fibrinogen and thrombin in the presence of calcium chloride as catalyst.
REFERENCES:
patent: 5516532 (1996-05-01), Atala et al.
Taneli et al, British Journal of Urology, vol. 74, No. 6, pp. 710-714, 1994.
Claes et al, The Journal of Urology, vol. 142, pp. 821-822, Sep. 1987.
Tsurusaki et al, The Journal of Urology, vol. 155, p. 1698, May 1966.
Volz et al., Zentralblatt Fur Gynajikigue, "Die Endoskopie des praperitonealen Intersitiums--ein neuer zugang fur die Kolposuspension", vol. 115, No. 11, pp. 488-491 (1993).
Dellas, Geburtshilfe Und Frauenheilkunde, "Kolposuspension mit Fibrinkleber", vol. 53, No. 9, p. 651 (1993).
Mohamed Abdel A.
Pinto Angelo
Tsang Cecilia J.
LandOfFree
Method of treating urinary incontinence does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of treating urinary incontinence, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating urinary incontinence will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1802828